Ace the Certified Emergency Nurse (CEN) Challenge 2025 – Energize Your Nursing Future!

A significant clinical indicator of heart failure is an elevated B-type natriuretic peptide (BNP) level, particularly above 100 pg/mL. BNP is a hormone produced by the heart’s ventricles in response to increased pressure that often occurs with heart failure. When the heart is unable to pump effectively, the cardiac workload increases, leading to a rise in BNP levels. Therefore, measuring BNP can be valuable in diagnosing heart failure, assessing its severity, and predicting patient outcomes.

In contrast, other options do not indicate heart failure as directly. Chest pain upon breathing could suggest various conditions, including pulmonary issues, but it is not specific to heart failure. A decreased heart size is typically associated with other cardiac conditions, such as hypertrophic cardiomyopathy, rather than heart failure, which is often characterized by an enlarged heart. Lastly, a low respiratory rate could occur in many different scenarios and is not a specific indicator of heart failure; in fact, patients with heart failure might present with increased respiratory rates due to fluid overload and pulmonary congestion. Thus, the elevation of BNP above 100 pg/mL serves as a direct indicator of heart failure and is crucial in clinical practice.